• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区居住的轻中度 COPD 老年患者的 FEV1 年下降率。

Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD.

机构信息

Division of Geriatric Medicine, Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.

出版信息

NPJ Prim Care Respir Med. 2022 Aug 26;32(1):30. doi: 10.1038/s41533-022-00292-w.

DOI:10.1038/s41533-022-00292-w
PMID:36028513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9418326/
Abstract

Information about the decline rate in forced expiratory volume in 1 s (FEV1s) in older adults with COPD is scarce. A total of 4082 community-dwelling older adults from the population-based study Good Aging in Skåne were followed for 12 years and 143 participants developed COPD. The average FEV1s decline is estimated to be 66.3 mL/year, (95% CI [56.4; 76.3]) and 43.3 mL/year (1.7%/year, 95% CI [41.2; 45.5]) for COPD and non-COPD participants, respectively.

摘要

有关慢性阻塞性肺疾病(COPD)老年患者 1 秒用力呼气容积(FEV1)下降率的信息很少。在这项基于人群的斯科讷良好老龄化研究中,共有 4082 名居住在社区的老年人随访了 12 年,其中 143 人患有 COPD。估计平均 FEV1 下降率为 66.3mL/年(95%CI [56.4; 76.3]),COPD 和非 COPD 参与者分别为 43.3mL/年(1.7%/年,95%CI [41.2; 45.5])。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f1/9418326/2dca8f87baf4/41533_2022_292_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f1/9418326/2dca8f87baf4/41533_2022_292_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f1/9418326/2dca8f87baf4/41533_2022_292_Fig1_HTML.jpg

相似文献

1
Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD.社区居住的轻中度 COPD 老年患者的 FEV1 年下降率。
NPJ Prim Care Respir Med. 2022 Aug 26;32(1):30. doi: 10.1038/s41533-022-00292-w.
2
Prevalence of chronic obstructive pulmonary disease in independent community-dwelling older adults: The Fujiwara-kyo study.独立社区居住的老年人群中慢性阻塞性肺疾病的流行情况:富士见町研究。
Geriatr Gerontol Int. 2017 Dec;17(12):2421-2426. doi: 10.1111/ggi.13091. Epub 2017 Jun 16.
3
Longitudinal changes in forced expiratory volume in 1 s in patients with eosinophilic chronic obstructive pulmonary disease.嗜酸粒细胞性慢性阻塞性肺疾病患者 1 秒用力呼气容积的纵向变化。
BMC Pulm Med. 2022 Mar 16;22(1):91. doi: 10.1186/s12890-022-01873-8.
4
Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease.呼气中期流速在有呼吸道症状但无慢性阻塞性肺疾病的社区老年居民中的诊断和预后价值
BMC Pulm Med. 2015 Jul 31;15:83. doi: 10.1186/s12890-015-0081-4.
5
People with COPD have greater participation restrictions than age-matched older adults without respiratory conditions assessed during the COVID-19 pandemic.在 COVID-19 大流行期间,与没有呼吸道疾病的年龄匹配的老年患者相比,COPD 患者的参与限制更大。
PLoS One. 2022 Oct 4;17(10):e0275264. doi: 10.1371/journal.pone.0275264. eCollection 2022.
6
Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.哥本哈根城市心脏研究中哮喘、慢性阻塞性肺疾病和哮喘-慢性阻塞性肺疾病重叠患者的长期预后:一项前瞻性基于人群的分析。
Lancet Respir Med. 2016 Jun;4(6):454-62. doi: 10.1016/S2213-2600(16)00098-9. Epub 2016 Apr 6.
7
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.中国慢性阻塞性肺疾病患病率及危险因素研究(CPH 研究):一项全国性横断面研究。
Lancet. 2018 Apr 28;391(10131):1706-1717. doi: 10.1016/S0140-6736(18)30841-9. Epub 2018 Apr 9.
8
Periodontitis Is Associated with Chronic Obstructive Pulmonary Disease.牙周炎与慢性阻塞性肺疾病有关。
J Dent Res. 2019 May;98(5):534-540. doi: 10.1177/0022034519833630. Epub 2019 Mar 8.
9
Reduced ambient PM better lung function, and decreased risk of chronic obstructive pulmonary disease.降低环境 PM 可改善肺功能,并降低慢性阻塞性肺疾病的风险。
Environ Int. 2021 Nov;156:106706. doi: 10.1016/j.envint.2021.106706. Epub 2021 Jun 18.
10
Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis.性别会调节 BMI 对轻中度 COPD 患者肺功能下降的影响:一项汇总分析。
Respir Res. 2021 Feb 18;22(1):59. doi: 10.1186/s12931-021-01656-5.

引用本文的文献

1
The prevalence and pattern of post tuberculosis lung disease including pulmonary hypertension from an Australian TB service; a single-centre, retrospective cohort study.澳大利亚一家结核病防治机构的肺结核后疾病(包括肺动脉高压)的患病率及模式:一项单中心回顾性队列研究
BMC Pulm Med. 2025 Feb 21;25(1):84. doi: 10.1186/s12890-025-03549-5.
2
Multi-ancestry genome-wide association study reveals novel genetic signals for lung function decline.多血统全基因组关联研究揭示了肺功能下降的新遗传信号。
medRxiv. 2024 Nov 27:2024.11.25.24317794. doi: 10.1101/2024.11.25.24317794.
3
Estimating rate of lung function change using clinical spirometry data.

本文引用的文献

1
Accelerated FEV decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients.慢性阻塞性肺疾病(COPD)初级保健人群中用力呼气量(FEV)加速下降与心血管疾病及死亡风险
Eur Respir J. 2021 Mar 4;57(3). doi: 10.1183/13993003.00918-2020. Print 2021 Mar.
2
The value of the Skåne Health-care Register: Prospectively collected individual-level data for population-based studies.斯科讷保健注册中心的价值:基于人群的前瞻性个体水平数据研究。
Scand J Public Health. 2020 Feb;48(1):56-63. doi: 10.1177/1403494819868042. Epub 2019 Dec 8.
3
Longitudinal decline in lung function: a community-based cohort study in Korea.
使用临床肺功能测定数据估计肺功能变化率。
BMJ Open Respir Res. 2024 Oct 3;11(1):e001896. doi: 10.1136/bmjresp-2023-001896.
4
Association of systemic anticholinergic medication use and accelerated decrease in lung function in older adults.系统使用抗胆碱能药物与老年人肺功能加速下降的关联。
Sci Rep. 2024 Feb 22;14(1):4362. doi: 10.1038/s41598-024-54879-z.
5
Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement.临床重要恶化(CID)和 COPD 中的衰老:根据 PRISMA 声明进行的系统评价和荟萃回归分析。
Int J Chron Obstruct Pulmon Dis. 2023 Oct 10;18:2225-2243. doi: 10.2147/COPD.S396945. eCollection 2023.
6
Cognitive decline and risk of dementia in older adults after diagnosis of chronic obstructive pulmonary disease.老年人慢性阻塞性肺疾病诊断后认知能力下降和痴呆风险。
NPJ Prim Care Respir Med. 2023 May 13;33(1):20. doi: 10.1038/s41533-023-00342-x.
肺功能的纵向下降:韩国的一项基于社区的队列研究。
Sci Rep. 2019 Sep 20;9(1):13614. doi: 10.1038/s41598-019-49598-9.
4
COPD overdiagnosis in primary care: a UK observational study of consistency of airflow obstruction.慢性阻塞性肺疾病在基层医疗中的过度诊断:一项英国观察性研究,评估气流阻塞的一致性。
NPJ Prim Care Respir Med. 2019 Aug 15;29(1):33. doi: 10.1038/s41533-019-0145-7.
5
Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies.老年人正常肺功能下降率:前瞻性队列研究的系统评价。
BMJ Open. 2019 Jun 27;9(6):e028150. doi: 10.1136/bmjopen-2018-028150.
6
Relative and absolute lung function change in a general population aged 60-102 years.60-102 岁一般人群的肺功能相对和绝对变化。
Eur Respir J. 2019 Mar 14;53(3). doi: 10.1183/13993003.01812-2017. Print 2019 Mar.
7
Risk factors for FEV decline in mild COPD and high-risk populations.轻度慢性阻塞性肺疾病和高危人群中第一秒用力呼气容积下降的危险因素。
Int J Chron Obstruct Pulmon Dis. 2017 Jan 27;12:435-442. doi: 10.2147/COPD.S118106. eCollection 2017.
8
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.全球慢性阻塞性肺疾病诊断、管理和预防策略 2017 年报告:GOLD 执行摘要。
Eur Respir J. 2017 Mar 6;49(3). doi: 10.1183/13993003.00214-2017. Print 2017 Mar.
9
Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study.吸烟者与非吸烟者中慢性阻塞性肺疾病的患病率和发病率:鹿特丹研究
Eur J Epidemiol. 2016 Aug;31(8):785-92. doi: 10.1007/s10654-016-0132-z. Epub 2016 Mar 5.
10
Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中功能性小气道疾病与第一秒用力呼气容积下降之间的关联
Am J Respir Crit Care Med. 2016 Jul 15;194(2):178-84. doi: 10.1164/rccm.201511-2219OC.